Ziopharm Oncology Receives Positive Opinion for Orphan Drug Designation from the European Medicines Agency for Ad-RTS-hIL-12 plus Veledimex for the Treatment of Glioma August 8, 2019 - NASDAQ Companies 0 » View More News for August 08, 2019
